{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:08:12Z","timestamp":1787800092620,"version":"build-2784847793"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T00:00:00Z","timestamp":1415577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T00:00:00Z","timestamp":1415577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1038\/bmt.2014.254","type":"journal-article","created":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T13:55:53Z","timestamp":1415714153000},"page":"259-265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Chimerism analysis in peripheral blood using indel quantitative real-time PCR is a useful tool to predict post-transplant relapse in acute leukemia"],"prefix":"10.1038","volume":"50","author":[{"given":"N","family":"Jacque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-L","family":"Golmard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Uzunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Garnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Leblond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-P","family":"Vernant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Bories","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Dh\u00e9din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,10]]},"reference":[{"key":"BFbmt2014254_CR1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1365-2141.1988.tb02488.x","volume":"70","author":"F Frassoni","year":"1988","unstructured":"Frassoni F, Barrett AJ, Gra\u00f1ena A, Ernst P, Garthon G, Kolb HJ et al. Relapse after a llogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 cases. Br J Haematol 1988; 70: 317\u2013320.","journal-title":"Br J Haematol"},{"key":"BFbmt2014254_CR2","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1200\/JCO.1994.12.8.1710","volume":"12","author":"L Kumar","year":"1994","unstructured":"Kumar L . Leukemia: management of relapse after allogeneic bone marrow transplantation. J Clin Oncol 1994; 12: 1710\u20131717.","journal-title":"J Clin Oncol"},{"key":"BFbmt2014254_CR3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1200\/JCO.1989.7.1.50","volume":"7","author":"J Mortimer","year":"1989","unstructured":"Mortimer J, Blinder MA, Schulman S, Appelbaum FR, Buckner CD, Clift RA et al. Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy. J Clin Oncol 1989; 7: 50\u201357.","journal-title":"J Clin Oncol"},{"key":"BFbmt2014254_CR4","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1093\/annonc\/mdn404","volume":"19","author":"MR Bishop","year":"2008","unstructured":"Bishop MR, Dean RM, Steinberg SM, Odom J, Pavletic SZ, Chow C et al. Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation. Ann Oncol 2008; 19: 1935\u20131940.","journal-title":"Ann Oncol"},{"key":"BFbmt2014254_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bbmt.2007.04.013","volume":"14","author":"AJC Bloor","year":"2008","unstructured":"Bloor AJC, Thomson K, Chowdhry N, Verfuerth S, Ings SJ, Chakraverty R et al. High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma. Biol Blood Marrow Transplant 2008; 14: 50\u201358.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014254_CR6","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/sj.bmt.1705898","volume":"41","author":"AW Loren","year":"2008","unstructured":"Loren AW, Porter DL . Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation. Bone Marrow Transplant 2008; 41: 483\u2013493.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014254_CR7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/sj.bmt.1700720","volume":"19","author":"J Mehta","year":"1997","unstructured":"Mehta J, Powles R, Treleaven J, Horton C, Meller S, Pinkerton CR et al. Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy. Bone Marrow Transplant 1997; 19: 709\u2013719.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014254_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev.med.50.1.369","volume":"50","author":"DL Porter","year":"1999","unstructured":"Porter DL, Antin JH . The graft-versus-leukemia effects of allogeneic cell therapy. Annu Rev Med 1999; 50: 369\u2013386.","journal-title":"Annu Rev Med"},{"key":"BFbmt2014254_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1200\/JCO.2002.20.2.405","volume":"20","author":"JE Levine","year":"2002","unstructured":"Levine JE, Braun T, Penza SL, Beatty P, Cornetta K, Martino R et al. Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation. J Clin Oncol 2002; 20: 405\u2013412.","journal-title":"J Clin Oncol"},{"key":"BFbmt2014254_CR10","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1038\/sj.leu.2403523","volume":"18","author":"S-J Choi","year":"2004","unstructured":"Choi S-J, Lee J-H, Lee J-H, Kim S, Seol M, Lee Y-S et al. Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse. Leukemia 2004; 18: 1789\u20131797.","journal-title":"Leukemia"},{"key":"BFbmt2014254_CR11","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"HJ Kolb","year":"1995","unstructured":"Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041\u20132050.","journal-title":"Blood"},{"key":"BFbmt2014254_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","volume":"15","author":"RH Collins Jr","year":"1997","unstructured":"Collins RH Jr, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433\u2013444.","journal-title":"J Clin Oncol"},{"key":"BFbmt2014254_CR13","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood.V95.8.2645","volume":"95","author":"DL Porter","year":"2000","unstructured":"Porter DL, Collins RH Jr, Hardy C, Kernan NA, Drobyski WR, Giralt S et al. Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions. Blood 2000; 95: 1214\u20131221.","journal-title":"Blood"},{"key":"BFbmt2014254_CR14","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.1200\/JCO.2007.11.6053","volume":"25","author":"C Schmid","year":"2007","unstructured":"Schmid C, Labopin M, Nagler A, Bornh\u00e4user M, Finke J, Fassas A et al. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party. J Clin Oncol 2007; 25: 4938\u20134945.","journal-title":"J Clin Oncol"},{"key":"BFbmt2014254_CR15","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1182\/blood-2011-09-380386","volume":"119","author":"C-H Yan","year":"2012","unstructured":"Yan C-H, Liu D-H, Liu K-Y, Xu L-P, Liu Y-R, Chen H et al. Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation. Blood 2012; 119: 3256\u20133262.","journal-title":"Blood"},{"key":"BFbmt2014254_CR16","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ctrv.2010.03.004","volume":"36","author":"A Deol","year":"2010","unstructured":"Deol A, Lum LG . Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited. Cancer Treat Rev 2010; 36: 528\u2013538.","journal-title":"Cancer Treat Rev"},{"key":"BFbmt2014254_CR17","first-page":"801","volume":"88","author":"M Barrios","year":"2003","unstructured":"Barrios M, Jim\u00e9nez-Velasco A, Rom\u00e1n-G\u00f3mez J, Madrigal ME, Castillejo JA, Torres A et al. Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia. Haematologica 2003; 88: 801\u2013810.","journal-title":"Haematologica"},{"key":"BFbmt2014254_CR18","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.3324\/haematol.2009.007765","volume":"94","author":"M Bornh\u00e4user","year":"2009","unstructured":"Bornh\u00e4user M, Oelschlaegel U, Platzbecker U, Bug G, Lutterbeck K, Kiehl MG et al. Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation. Haematologica 2009; 94: 1613\u20131617.","journal-title":"Haematologica"},{"key":"BFbmt2014254_CR19","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1038\/sj.leu.2403507","volume":"18","author":"C Scheffold","year":"2004","unstructured":"Scheffold C, Kroeger M, Zuehlsdorf M, Tchinda J, Silling G, Bisping G et al. Prediction of relapse of acute myeloid leukemia in allogeneic transplant recipients by marrow CD34+ donor cell chimerism analysis. Leukemia 2004; 18: 2048\u20132050.","journal-title":"Leukemia"},{"key":"BFbmt2014254_CR20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/MOH.0b013e32834bac7d","volume":"18","author":"A Dominietto","year":"2011","unstructured":"Dominietto A . Minimal residual disease markers before and after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. Curr Opin Hematol 2011; 18: 381\u2013387.","journal-title":"Curr Opin Hematol"},{"key":"BFbmt2014254_CR21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1100\/tsw.2011.16","volume":"11","author":"U Bacher","year":"2011","unstructured":"Bacher U, Haferlach T, Fehse B, Schnittger S, Kr\u00f6ger N . Minimal residual disease diagnostics and chimerism in the post-transplant period in acute myeloid leukemia. ScientificWorldJournal 2011; 11: 310\u2013319.","journal-title":"ScientificWorldJournal"},{"key":"BFbmt2014254_CR22","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.1182\/blood.V99.12.4618","volume":"99","author":"M Alizadeh","year":"2002","unstructured":"Alizadeh M, Bernard M, Danic B, Dauriac C, Birebent B, Lapart C et al. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood 2002; 99: 4618\u20134625.","journal-title":"Blood"},{"key":"BFbmt2014254_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4161\/chim.23158","volume":"4","author":"M Kletzel","year":"2013","unstructured":"Kletzel M, Huang W, Olszewski M, Khan S . Validation of chimerism in pediatric recipients of allogeneic hematopoietic stem cell transplantation (HSCT) a comparison between two methods: real-time PCR (qPCR) vs. variable number tandem repeats PCR (VNTR PCR). Chimerism 2013; 4: 1\u20138.","journal-title":"Chimerism"},{"key":"BFbmt2014254_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1751-553X.2010.01249.x","volume":"33","author":"O Horky","year":"2011","unstructured":"Horky O, Mayer J, Kablaskova L, Razga F, Krejci M, Kissova J et al. Increasing hematopoietic microchimerism is a reliable indicator of incipient AML relapse. Int J Lab Hematol 2011; 33: 57\u201366.","journal-title":"Int J Lab Hematol"},{"key":"BFbmt2014254_CR25","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/sj.leu.2403622","volume":"19","author":"A Jim\u00e9nez-Velasco","year":"2005","unstructured":"Jim\u00e9nez-Velasco A, Barrios M, Rom\u00e1n-G\u00f3mez J, Navarro G, Bu\u00f1o I, Castillejo JA et al. Reliable quantification of hematopoietic chimerism after allogeneic transplantation for acute leukemia using amplification by real-time PCR of null alleles and insertion\/deletion polymorphisms. Leukemia 2005; 19: 336\u2013343.","journal-title":"Leukemia"},{"key":"BFbmt2014254_CR26","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.exphem.2010.08.006","volume":"38","author":"B Wiedemann","year":"2010","unstructured":"Wiedemann B, Klyuchnikov E, Kr\u00f6ger N, Zabelina T, Stahl T, Zeschke S et al. Chimerism studies with quantitative real-time PCR in stem cell recipients with acute myeloid leukemia. Exp Hematol 2010; 38: 1261\u20131271.","journal-title":"Exp Hematol"},{"key":"BFbmt2014254_CR27","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945\u2013956.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014254_CR28","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","volume":"21","author":"BD Cheson","year":"2003","unstructured":"Cheson BD, Bennett JM, Kopecky KJ, B\u00fcchner T, Willman CL, Estey EH et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 2003; 21: 4642\u20134649.","journal-title":"J Clin Oncol"},{"key":"BFbmt2014254_CR29","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/leu.2012.66","volume":"26","author":"T Lion","year":"2012","unstructured":"Lion T, Watzinger F, Preuner S, Kreyenberg H, Tilanus M, de Weger R et al. The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation. Leukemia 2012; 26: 1821\u20131828.","journal-title":"Leukemia"},{"key":"BFbmt2014254_CR30","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/sj.bmt.1701119","volume":"21","author":"P Bader","year":"1998","unstructured":"Bader P, Beck J, Frey A, Schlegel PG, Hebarth H, Handgretinger R et al. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant 1998; 21: 487\u2013495.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014254_CR31","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1038\/sj.leu.2402311","volume":"15","author":"J Mattsson","year":"2001","unstructured":"Mattsson J, Uzunel M, Tammik L, Aschan J, Ringd\u00e9n O . Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation. Leukemia 2001; 15: 1976\u20131985.","journal-title":"Leukemia"},{"key":"BFbmt2014254_CR32","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/ajh.20693","volume":"81","author":"M Koldehoff","year":"2006","unstructured":"Koldehoff M, Steckel NK, Hlinka M, Beelen DW, Elmaagacli AH . Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences. Am J Hematol 2006; 81: 735\u2013746.","journal-title":"Am J Hematol"},{"key":"BFbmt2014254_CR33","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/tid.12101","volume":"15","author":"S Borchers","year":"2013","unstructured":"Borchers S, Weissinger EM, Pabst B, Ganzenmueller T, Dammann E, Luther S et al. Expansion of recipient-derived antiviral T cells may influence donor chimerism after allogeneic stem cell transplantation. Transpl Infect Dis 2013; 15: 627\u2013633.","journal-title":"Transpl Infect Dis"},{"key":"BFbmt2014254_CR34","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.bbmt.2010.10.031","volume":"17","author":"N Kr\u00f6ger","year":"2011","unstructured":"Kr\u00f6ger N, Miyamura K, Bishop MR . Minimal residual disease following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011; 17: S94\u2013100.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014254_CR35","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.1182\/blood-2011-04-348805","volume":"118","author":"E Rettinger","year":"2011","unstructured":"Rettinger E, Willasch AM, Kreyenberg H, Borkhardt A, Holter W, Kremens B et al. Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation. Blood 2011; 118: 5681\u20135688.","journal-title":"Blood"},{"key":"BFbmt2014254_CR36","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1200\/JCO.2004.05.198","volume":"22","author":"P Bader","year":"2004","unstructured":"Bader P, Kreyenberg H, Hoelle W, Dueckers G, Handgretinger R, Lang P et al. Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy? J Clin Oncol 2004; 22: 1696\u20131705.","journal-title":"J Clin Oncol"},{"key":"BFbmt2014254_CR37","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/sj.bmt.1704444","volume":"33","author":"P Bader","year":"2004","unstructured":"Bader P, Kreyenberg H, Hoelle W, Dueckers G, Kremens B, Dilloo D et al. Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective. Bone Marrow Transplant 2004; 33: 815\u2013821.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014254_CR38","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/sj.leu.2403719","volume":"19","author":"R Zeiser","year":"2005","unstructured":"Zeiser R, Spyridonidis A, W\u00e4sch R, Ihorst G, Gr\u00fcllich C, Bertz H et al. Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation. Leukemia 2005; 19: 814\u2013821.","journal-title":"Leukemia"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2014254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2014254","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2014254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T18:14:11Z","timestamp":1648059251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2014254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,10]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["BFbmt2014254"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2014.254","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,10]]},"assertion":[{"value":"4 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}